Protagenic Therapeutics share price logo

Protagenic Therapeutics

OTC: PTIX

$1.06

+0.06

(+6.00%)

as on

Protagenic Therapeutics Stock Performance

as on September 5, 2026 at 3:22 am IST

  • Day's Low

    $0.95
    $1.06
    downward going graph

    10.38%

    Downside

  • 52 Week's Low

    52 Week's High

    $0.13
    $4.55
    downward going graph

    87.91%

    Downside

    329.25%

    Upside

    downward going graph

Protagenic Therapeutics share price movements today

Previous Close
$1.00
Open
$0.95
Volume
34.1K
Market Cap
$1.9M
Day's Low - High
$0.95 - $1.06
52 Week Low - High
$0.13 - $4.55

Protagenic Therapeutics Historical Returns

1 Month Return
+ 376.19 %
3 Month Return
+ 100 %
1 Year Return
-67.74 %
3 Year Return
-96.1 %
5 Year Return
-99.17 %

Protagenic Therapeutics Stock Fundamentals & Key Indicators

Check Protagenic Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9M

EPS (TTM)

2.95

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.34

Industry PE ratio

-4.00

PEG Ratio

0.0010118170648447736

EBITDA

-4.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-794.18%

Protagenic Therapeutics Stock Valuation

Track how Protagenic Therapeutics P/E has moved over time to understand its valuation trends.

Protagenic Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-63.19x)

December 31, 2021

Industry (-4.00x)

December 31, 2025

Today (-0.38x)

December 31, 2025

Highest (-0.38x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.38x

Protagenic Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protagenic Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$1.9M-99.17%0.340.00%NA
BUY$27.7B344.34%NA-76.94%NA
BUY$35.8B33.95%42.9216.13%NA
BUY$141.1B181.73%32.2186.04%NA
BUY$84.8B24.12%20.1484.86%0.44%

Stock Returns calculator for Protagenic Therapeutics Stock including INR - Dollar returns

The Protagenic Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Protagenic Therapeutics investment value today

Current value as on today

₹36,633

Returns

-₹63,367

(-63.37%)

Returns from Protagenic Therapeutics Stock

-₹65,806 (-65.81%)

Dollar Impact

₹2,439 (+2.44%)

Analyst Recommendation on Protagenic Therapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Protagenic Therapeutics. Average target price of $4

Protagenic Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Protagenic Therapeutics.

What analysts predicted

73.5%UPSIDE

Target Price

$4

Current Price

$1.06

Analyzed by

7 Analysts

Target

$4.00

Protagenic Therapeutics target price $4, a slight upside of 73.5% compared to current price of $1.06. According to 7 analysts rating.

Protagenic Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
0
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-1
-1
0
-1
-1
-2
-1
0
-1
0
EBITDA
-1
-1
0
-1
-1
-4
0
0
-1
0
Interest Expense
-
-
-
-
-
0
0
-
1
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
0
-1
-1
-5
0
2
5
0
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
-1
0
-1
-1
-5
0
2
5
0
Net Profit Margin
0.00%
0.00%
0.00%
200.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Protagenic Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
-
0
0
0
0
Operating Income
-2
-2
-2
-2
-4
-3
-4
-5
-5
EBITDA
-2
-2
-2
-2
-4
-3
-4
-5
-8
Interest Expense
0
0
0
0
0
0
0
-
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-2
-2
-1
-2
-4
-3
-5
-5
-5
Income Tax Expense
-
-
0
-
-
-
-
-
-
Net Income
-2
-2
-1
-2
-4
-3
-5
-5
-5
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Protagenic Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-1
-1
0
-1
-1
-5
-4
5
5
0
Operating Cash Flow
-1
-1
0
0
-1
-1
-1
0
0
0
Investing Cash Flow
1
1
-
-
-
0
0
0
0
-
Financing Cash Flow
-
0
0
1
0
4
0
-
0
-
Change in Cash
0
0
0
0
0
4
1
0
0
0

Protagenic Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Mar 2024
Dec 2024
Dec 2025
Net Income
-2
-2
-1
-2
-4
-3
-5
-5
-5
Operating Cash Flow
-1
-1
0
-1
-2
-1
-3
-4
-4
Investing Cash Flow
-1
1
0
-
-9
1
4
2
0
Financing Cash Flow
-
-
0
1
12
-
-
1
4
Change in Cash
-2
0
0
0
0
0
1
0
4

Global Institutional Holdings in Protagenic Therapeutics

Funds
Holdings
Bank of America Corp
0%
Morgan Stanley - Brokerage Accounts
0%
Vanguard Group Inc
0%
Susquehanna International Group, LLP
0%
Advisor Group Holdings, Inc.
0%

Insights on Protagenic Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Insmed Incorporated has given 165.0% return, outperforming this stock by 257.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Insmed Incorporated has given 847.0% return, outperforming this stock by 944.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, PTIX stock has moved down by -56.2%

About Protagenic Therapeutics

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. The company was founded in 2004 and is based in New York, New York.
OrganisationProtagenic Therapeutics
Headquarters149 Fifth Avenue, New York, NY, United States, 10010
IndustryBiotechnology
CEODr. Garo H. Armen Ph.D.
E-voting on sharesClick here to vote

Key Management of Protagenic Therapeutics

Name

Title

Dr. Garo H. Armen Ph.D.

Executive Chairman

Mr. William Nichols Jr.

President

Dr. Robert Benjamin Stein M.D., Ph.D.

Chief Medical Officer

FAQs

What is Protagenic Therapeutics share price today?

Protagenic Therapeutics share price today is $1.06 as on at the close of the market. Protagenic Therapeutics share today touched a day high of $1.06 and a low of $0.95.

What is the 52 week high and 52 week low for Protagenic Therapeutics share?

Protagenic Therapeutics share touched a 52 week high of $4.55 on and a 52 week low of $0.13 on . Protagenic Therapeutics stock price today i.e. is closed at $1.06,which is 76.70% down from its 52 week high and 726.83% up from its 52 week low.

What is Protagenic Therapeutics's market capitalisation today?

Protagenic Therapeutics market capitalisation is $0.00T as on .

How to invest in Protagenic Therapeutics Stock (PTIX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Protagenic Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protagenic Therapeutics Shares that will get you 1.4151 shares as per Protagenic Therapeutics share price of $1.06 per share as on September 4, 2026 at 9:52 pm IST.

What is the minimum amount required to buy Protagenic Therapeutics Stock (PTIX) from India?

Indian investors can start investing in Protagenic Therapeutics (PTIX) shares with as little as ₹94.485 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.85 in Protagenic Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Protagenic Therapeutics share’s latest price of $1.06 as on September 4, 2026 at 9:52 pm IST, you will get 9.4340 shares of Protagenic Therapeutics. Learn more about fractional shares .

What are the returns that Protagenic Therapeutics has given to Indian investors in the last 5 years?

Protagenic Therapeutics stock has given -99.17% share price returns and 29.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?